Véronique Zerr

Title: Innovations of Véronique Zerr in Antimalarial Research

Introduction

Véronique Zerr is a notable inventor based in Paris, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antimalarial agents. His work focuses on creating novel compounds that can inhibit the growth of parasites responsible for malaria.

Latest Patents

Véronique Zerr holds a patent for "Pyrimidinone derivatives as antimalarial agents." This invention relates to novel pyrimidinone-based heterocyclic compounds that serve as parasite growth inhibitors. The general formula of these compounds includes specific structural elements, where Y is a morpholine selected from three bridged morpholines, L represents a bond or a linker, n can be 0 or 1, and R is a methyl group when n=0 and a hydrogen atom when n=1. The patent also outlines the process for the preparation of these compounds and their therapeutic use.

Career Highlights

Véronique Zerr is currently associated with Sanofi, a leading global healthcare company. His role at Sanofi allows him to engage in cutting-edge research and development in the pharmaceutical sector. His innovative work has the potential to contribute significantly to the fight against malaria.

Collaborations

Some of his notable coworkers include Youssef El-Ahmad and Bruno Filoche-Romme. Their collaboration enhances the research efforts at Sanofi, fostering an environment of innovation and discovery.

Conclusion

Véronique Zerr's contributions to antimalarial research through his patented innovations highlight the importance of scientific advancements in combating infectious diseases. His work exemplifies the critical role of inventors in the pharmaceutical industry.